Antigen News and Research

RSS

Synthetic antibodies constructed using bacterial superglue could help fight lethal viruses

Synthetic antibodies constructed using bacterial superglue can neutralize potentially lethal viruses, according to a study published on April 21 in eLife.

28 Apr 2020

Duke engineers awarded NSF grant to adapt fast, low-cost diagnostic tool for COVID-19

Biomedical engineers at Duke University are adapting a rapid testing platform originally designed to detect Ebola to see whether it could be of use in detecting antigens to SARS-Cov-2, the virus that causes COVID-19.

27 Apr 2020

Researchers report promising new therapy for recurrent pediatric brain cancers

Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy.

27 Apr 2020

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

A new study reports the induction of high levels of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing the current pandemic of COVID-19. This promising finding was reported on the preprint server bioRxiv on April 2020.

26 Apr 2020

Mapping complex peripheral immune response to severe COVID-19

In a recent article publicly available at medRxiv, researchers from Stanford have presented a single-cell atlas of the peripheral immune response to coronavirus disease (COVID-19), highlighting pertinent immunological features associated with the severe forms of the disease.

26 Apr 2020

American Lung Association calls for urgent universal COVID-19 antibody testing

The COVID-19 pandemic has resulted in unprecedented rates of lung infections and deaths in modern history.

24 Apr 2020

First COVID-19-related clinical trial to start in Germany

German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.

24 Apr 2020

Research looks at best ways to tackle coronavirus crisis

A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.

24 Apr 2020

EPFL scientists identify new therapeutic target for Non-Hodgkin lymphoma

Non-Hodgkin lymphoma is a group of cancers that originate in the lymph nodes and affect white blood cells of the immune system called B cells.

23 Apr 2020

Using 'own' immune cells to fight infectious diseases including COVID-19

A provocative paper from Duke-NUS Medical School, published in the Journal of Experimental Medicine in March 2020, discusses the possibilities of creating new receptors on a sick person's own immune cells as a means of controlling the infection. This therapy is already being used to treat certain cancers with marked success.

22 Apr 2020

Have we found a new malaria vaccine?

A new study published in the journal Nature in April 2020 reports on a malaria protein antibody that appears to protect resistant children from severe disease, showing promise in the fight against malaria, a new study found. Almost 500,000 people die of malaria every year.

22 Apr 2020

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta Group plc is pleased to announce that it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen.

From Avacta Life Sciences Ltd. 22 Apr 2020

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Accelerating antibody discovery using picodroplet technology for single cell analysis to condense discovery times down to 1-2 days.

From Sphere Fluidics 22 Apr 2020

New findings could make immunotherapy treatments effective for more cancer patients

Scientists have developed a new way to map the molecules on tumour cells that flag their presence to the immune system, according to a study published today in eLife.

22 Apr 2020

Researchers are exploring potential therapy for controlling infectious diseases

The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS), as a potential therapy for controlling infectious diseases, including the COVID-19-causing virus, SARS-CoV-2.

22 Apr 2020

Researchers develop new 3D multicomponent dissolvable vaccine platform

In parallel to their current work on a potential coronavirus vaccine, researchers at the University of Pittsburgh School of Medicine have developed a new vaccine delivery system for vaccines using live or attenuated viral vectors: a finger-tip sized patch that contains 400 tiny needles, each just half of one millimeter.

21 Apr 2020

Immunity to coronavirus infection may help stem the pandemic

The raging coronavirus pandemic is causing immense fear and uncertainty across the world. One of the most distressing aspects of COVID-19 disease is the seemingly large number of unknowns. These include the burning question of immunity. Does a person who was sick with the COVID-19 and then recovered or was infected without symptoms, have immunity against re-infection?

21 Apr 2020

Antigen News and Research

Synthetic antibodies constructed using bacterial superglue could help fight lethal viruses

Duke engineers awarded NSF grant to adapt fast, low-cost diagnostic tool for COVID-19

Researchers report promising new therapy for recurrent pediatric brain cancers

Recombinant protein produces neutralizing COVID-19 antibodies in primate model

Mapping complex peripheral immune response to severe COVID-19

American Lung Association calls for urgent universal COVID-19 antibody testing

First COVID-19-related clinical trial to start in Germany

Research looks at best ways to tackle coronavirus crisis

EPFL scientists identify new therapeutic target for Non-Hodgkin lymphoma

Using 'own' immune cells to fight infectious diseases including COVID-19

Have we found a new malaria vaccine?

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

New findings could make immunotherapy treatments effective for more cancer patients

Researchers are exploring potential therapy for controlling infectious diseases

Researchers develop new 3D multicomponent dissolvable vaccine platform

Immunity to coronavirus infection may help stem the pandemic

Sino Biological Partners with Nanommune Inc. to Develop and Market a Novel Coronavirus Multiplex Serological Assay

Bio-Rad Introduces Anti-Ipilimumab Antibodies

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News